Shared circulation in parabiosis leads to the transfer of bone phenotype from gld to the wild-type mice

Cellular Immunology

Volumn 233, Issue 2, 2005, Pages 133-139

  Lukić, Ivan Krešimir ^a   Kovačić, Nataša ^a   Katavić, Vedran ^a   Grčević, Danka ^a   Ivčević, Sanja ^a   Marušić, Ana ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Antigens; Autoimmunity; Bone marrow cells; CD95; Parabiosis

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD; BONE MARROW; BONE MARROW CULTURE; CELL COUNT; CELL CULTURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; LYMPH NODE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PARABIOSIS; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; WILD TYPE;

ANIMALS; BLOOD CIRCULATION; BONE AND BONES; BONE MARROW CELLS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, INBRED C57BL; PARABIOSIS; PHENOTYPE;

ANIMALIA;

EID: 23044455954     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.04.010     Document Type: Conference Paper

References (44)

1. S.L. Teitelbaum, and F.P. Ross Genetic regulation of osteoclast development and function Nat. Rev. Genet. 4 2003 638 649
2. D. Grcevic, V. Katavic, I.K. Lukic, N. Kovacic, J.A. Lorenzo, and A. Marusic Cellular and molecular interactions between immune system and bone Croat. Med. J. 42 2001 384 392
3. M.C. Horowitz, and J.A. Lorenzo The origins of osteoclasts Curr. Opin. Rheumatol. 16 2004 464 468
4. P. Bianco, and P. Gehron Robey Marrow stromal stem cells J. Clin. Invest. 105 2000 1663 1668
5. T. Miyamoto, O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D.M. Anderson, and T. Suda Bifurcation of osteoclasts and dendritic cells from common progenitors Blood 98 2001 2544 2554
6. A. Ashkenazi Targeting death and decoy receptors of the tumour-necrosis factor superfamily Nat. Rev. Cancer 2 2002 420 430
7. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat. Rev. Immunol. 3 2003 745 756
8. K. Pfeffer Biological functions of tumor necrosis factor cytokines and their receptors Cytokine Growth Factor Rev. 14 2003 185 191
9. R.M. Siegel, F.K. Chan, H.J. Chun, and M.J. Lenardo The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity Nat. Immunol. 1 2000 469 474
10. P.H. Krammer CD95's deadly mission in the immune system Nature 407 2000 789 795
11. Y. Laouar, A. Sarukhan, V. Pasqualetto, C. Garcia, and S. Ezine Involvement of the Fas (CD95) system in peripheral cell death and lymphoid organ development Eur. J. Immunol. 28 1998 1078 1088
12. T. Takahashi, M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand Cell 76 1994 969 976
13. + T cells J. Immunol. 146 1991 4138 4148
14. Y. Refaeli, L. Van Parijs, and A.K. Abbas Genetic models of abnormal apoptosis in lymphocytes Immunol. Rev. 169 1999 273 282
15. P.L. Cohen, and R.A. Eisenberg The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane Immunol. Today 13 1992 427 428
16. E.S. Sobel, V.N. Kakkanaiah, R.G. Rapoport, R.A. Eisenberg, and P.L. Cohen The abnormal lpr double-negative T cell fails to proliferate in vivo Clin. Immunol. Immunopathol. 74 1995 177 184
17. V. Katavic, D. Grcevic, I.K. Lukic, V. Vucenik, N. Kovacic, I. Kalajzic, and A. Marusic Non-functional Fas ligand increases the formation of cartilage early in the endochondral bone induction by rhBMP-2 Life Sci. 74 2003 13 28
18. S. Mori, M. Nose, M. Chiba, K. Narita, M. Kumagai, H. Kosaka, and T. Teshima Enhancement of ectopic bone formation in mice with a deficit in Fas-mediated apoptosis Pathol. Int. 47 1997 112 116
19. V. Katavic, I.K. Lukic, N. Kovacic, D. Grcevic, J.A. Lorenzo, and A. Marusic Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse J. Immunol. 170 2003 1540 1547
20. J. Lorenzo Interactions between immune and bone cells: new insights with many remaining questions J. Clin. Invest. 106 2000 749 752
21. J. Rho, M. Takami, and Y. Choi Osteoimmunology: interactions of the immune and skeletal systems Mol. Cells 17 2004 1 9
22. N. Udagawa The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis J. Bone Miner. Metab. 21 2003 337 343
23. G. Duque, K. El Abdaimi, J.E. Henderson, A. Lomri, and R. Kremer Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways Bone 35 2004 57 64
24. D.E. Wright, A.J. Wagers, A.P. Gulati, F.L. Johnson, and I.L. Weissman Physiological migration of hematopoietic stem and progenitor cells Science 294 2001 1933 1936
25. D. Grcevic, S.K. Lee, A. Marusic, and J.A. Lorenzo Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis J. Immunol. 165 2000 4231 4238
26. S. Dacic, I. Kalajzic, D. Visnjic, A.C. Lichtler, and D.W. Rowe Col1a1-driven transgenic markers of osteoblast lineage progression J. Bone Miner. Res. 16 2001 1228 1236
27. T. Suda, and S. Nagata Why do defects in the Fas-Fas ligand system cause autoimmunity J. Allergy Clin. Immunol. 100 1997 S97 S101
28. E.S. Sobel, V.N. Kakkanaiah, P.L. Cohen, and R.A. Eisenberg Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene Int. Immunol. 5 1993 1275 1278
29. T. Kobata, K. Takasaki, H. Asahara, N.M. Hong, K. Masuko-Hongo, T. Kato, S. Hirose, T. Shirai, N. Kayagaki, H. Yagita, K. Okumura, and K. Nishioka Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice Immunology 92 1997 206 213
30. S. Epstein Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton J. Bone Miner. Res. 11 1996 1 7
31. M. Ballow, and R. Nelson Immunopharmacology: immunomodulation and immunotherapy JAMA 278 1997 2008 2017
32. V.N. Kakkanaiah, G.C. MacDonald, P.L. Cohen, and R.A. Eisenberg Suppression and reversal of gld disease by parabiosis with normal mice Clin. Immunol. Immunopathol. 78 1996 6 13
33. K. Fecho, S.A. Bentley, and P.L. Cohen Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis Cell. Immunol. 188 1998 19 32
34. H. Korner, E. Cretney, P. Wilhelm, J.M. Kelly, M. Rollinghoff, J.D. Sedgwick, and M.J. Smyth Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype J. Exp. Med. 191 2000 89 96
35. E.A. Reap, M.L. Piecyk, A. Oliver, E.S. Sobel, T. Waldschmidt, P.L. Cohen, and R.A. Eisenberg Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice Clin. Immunol. Immunopathol. 78 1996 21 29
36. A. Kawakami, K. Eguchi, N. Matsuoka, M. Tsuboi, T. Koji, S. Urayama, K. Fujiyama, T. Kiriyama, T. Nakashima, P.K. Nakane, and S. Nagataki Fas and Fas ligand interaction is necessary for human osteoblast apoptosis J. Bone Miner. Res. 12 1997 1637 1646
37. E. Lepri, D.V. Delfino, G. Migliorati, R. Moraca, E. Ayroldi, and C. Riccardi Functional expression of Fas on mouse bone marrow stromal cells: upregulation by tumor necrosis factor-α and interferon-γ Exp. Hematol. 26 1998 1202 1208
38. N. Ozeki, M. Mogi, H. Nakamura, and A. Togari Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells Arch. Oral Biol. 47 2002 511 517
39. S. Cenci, M.N. Weitzmann, C. Roggia, N. Namba, D. Novack, J. Woodring, and R. Pacifici Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α J. Clin. Invest. 106 2000 1229 1237
40. S. Cenci, G. Toraldo, M.N. Weitzmann, C. Roggia, Y. Gao, W.P. Qian, O. Sierra, and R. Pacifici Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator Proc. Natl. Acad. Sci. USA 100 2003 10405 10410
41. S. Kotake, N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M.T. Gillespie, T.J. Martin, and T. Suda IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J. Clin. Invest. 103 1999 1345 1352
42. L. Rifas Bone and cytokines: beyond IL-1, IL-6 and TNF-α Calcif. Tissue Int. 64 1999 1 7
43. G.D. Roodman Role of cytokines in the regulation of bone resorption Calcif. Tissue Int. 53 Suppl. 1 1993 S94 S98
44. M.N. Weitzmann, S. Cenci, L. Rifas, J. Haug, J. Dipersio, and R. Pacifici T cell activation induces human osteoclast formation via receptor activator of nuclear factor κB ligand-dependent and -independent mechanisms J. Bone Miner. Res. 16 2001 328 337